SHL TELEMEDICINE LTD. Press release
SHL announces decisions of Special General Meeting
Tel Aviv / Zurich, 5 January 2017 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY) ("SHL"), a leading provider and developer of advanced personal telemedicine solutions, announces that all resolutions at today's Special General Meeting of the Shareholders were accepted and that Mr. Ronen Harel was elected as new Independent (External) Director to the Board of Directors for a three-year term.
About SHL Telemedicine
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and has an ADR program listed over-the counter; Symbol: SMDCY. For more information, please visit the web site at www.shl-telemedicine.com.
For further information, please contact:
Martin Meier-Pfister, IRF Communications, phone: +41 43 244 81 40, shl@irfcom.ch
Ehud Ben-Yair, CFO, ehudb@shl-telemedicine.com
| Provider | Channel | Contact | ||
|---|---|---|---|---|
|
Tensid EQS Ltd., Switzerland www.tensid.ch |
newsbox.ch www.newsbox.ch |
Provider/Channel related enquiries marco@tensid.ch +41 41 763 00 50 |
